Abbott’s defibrillation lead lands FDA approval and CE mark

Coverage, in order

1. 2d ago
   
   first Cardiovascular Business indie

   FDA approves Abbott’s new defibrillation lead for conduction system pacing

   The UltiSynq defibrillation lead from Abbott gives clinicians a new option for left bundle branch area pacing. The device has also received CE mark approval.

2. 12h ago
   
   MedTech Dive indie

   Abbott’s defibrillation lead lands FDA approval and CE mark

   The authorizations position Abbott to launch a purpose-built lead for left bundle branch area pacing in the U.S. and Europe.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.